DEPT
FACULTY
COVID-19 Contribution
14 Dec 2022
The high effectiveness of the third dose of BNT162b2 in healthy adolescents against Omicron BA.1 has been reported in some studies, but immune respons...Read more
05 May 2022
Background: Omicron subvariant BA.2 circulation is rapidly increasing globally. Aim: We evaluated the neutralising antibody response from vaccination ...Read more
13 Sep 2022
We administered BNT162b2 as a third dose to 314 adults aged ≥30 years who had previously received 2 doses of inactivated vaccine. We collected blood s...Read more
06 Mar 2023
Introduction: Two doses of inactivated SARS-CoV-2 vaccine CoronaVac cannot elicit high efficacy against symptomatic COVID-19, especially against the O...Read more
08 Jun 2022
Background: Limited data exist on antibody responses to mixed vaccination strategies that involve inactivated coronavirus disease 2019 (COVID-19) vacc...Read more
01 Mar 2022
The Omicron variant is rapidly becoming the dominant SARS-CoV-2 virus circulating globally. It is important to define reductions in virus neutralizing...Read more
04 Aug 2023
Few trials have compared homologous and heterologous third doses of COVID-19 vaccination with inactivated vaccines and mRNA vaccines. The aim of this ...Read more